NCT05631769View on ClinicalTrials.gov

HOST - DAPT Duration According the Bleeding Risk

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

4,900

Participants

Timeline

Start Date

July 24, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Coronary Artery DiseaseAcute Myocardial InfarctionStable Angina
Interventions
DRUG

Dual antiplatelet agent duration

"Patients who receive percutaneous coronary intervention for coronary artery disease will be randomized to arms with different DAPT strategies.~The randomization will be stratified according to the High bleeding risk (defined according to the ARC-HBR criteria)."

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Hanyang University Seoul Hospital

OTHER

lead

Seoul National University Hospital

OTHER